Barclays
BMR

Barclays’s BIOMED REALTY TRUST INC BMR Stock Holding History

Barclays’s Portfolio BMR Stock Details BMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,300
Closed -$48K – 7987
2014
Q2 		$48K Buy
+2,300
New +$48.9K ﹤0.01% 5980

Other funds holding BMR

UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
MAM
Mizuho Asset Management Tokyo, Japan $462M AUM 15.39% 1-Year Est. Return
KB
Kimelman & Baird New York $1.22B AUM 11.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's BMR Position: Q1 2016 in Review

Barclays sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 227,499 shares — an estimated $5.23M sold.

Barclays first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $24M in Q4 2013. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Barclays reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 227,499 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $5.23M.
  • Barclays first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Barclays's BIOMED REALTY TRUST INC position peaked at $24M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.